Graphene FET Sensors for Alzheimer’s Disease Protein Biomarker Clusterin Detection
Authors:
Open Access
- 26 March 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 8
Abstract
We report on the fabrication and characterisation of graphene field-effect transistor (GFET) biosensors for the detection of Clusterin, a prominent protein biomarker of Alzheimer’s disease (AD). The GFET sensors were fabricated on Si/SiO2 substrate using photolithographic patterning and metal lift-off techniques with evaporated chromium and sputtered gold contacts. Raman Spectroscopy was performed on the devices to determine the quality of the graphene. The GFETs were annealed to improve their performance before the channels were functionalized by immobilising the graphene surface with linker molecules and anti-Clusterin antibodies. Concentration of linker molecules was also independently verified by absorption spectroscopy using the highly collimated micro-beam light of Diamond B23 beamline. The detection was achieved through the binding reaction between the antibody and varying concentrations of Clusterin antigen from 1 to 100 pg/mL, as well as specificity tests using human chorionic gonadotropin (hCG), a glycoprotein risk biomarker of certain cancers. The GFETs were characterized using direct current (DC) 4-probe electrical resistance (4-PER) measurements, which demonstrated a limit of detection of the biosensors to be ∼ 300 fg/mL (4 fM). Comparison with back-gated Dirac voltage shifts with varying concentration of Clusterin show 4-PER measurements to be more accurate, at present, and point to a requirement for further optimisation of the fabrication processes for our next generation of GFET sensors. Thus, we have successfully fabricated a promising set of GFET biosensors for the detection of Clusterin protein biomarker. The developed GFET biosensors are entirely generic and also have the potential to be applied to a variety of other disease detection applications such as Parkinson’s, cancer, and cardiovascular.Keywords
Funding Information
- Engineering and Physical Sciences Research Council
This publication has 71 references indexed in Scilit:
- Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairmentNeuroImage, 2012
- The effect of chemical residues on the physical and electrical properties of chemical vapor deposited graphene transferred to SiO2Applied Physics Letters, 2011
- Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer DiseaseArchives of General Psychiatry, 2010
- Electrical Detection of DNA Hybridization with Single‐Base Specificity Using Transistors Based on CVD‐Grown Graphene SheetsAdvanced Materials, 2010
- Phonon softening and crystallographic orientation of strained graphene studied by Raman spectroscopyProceedings of the National Academy of Sciences, 2009
- Raman Spectrum of Graphene and Graphene LayersPhysical Review Letters, 2006
- Purification and Characterization of Brain ClusterinBiochemical and Biophysical Research Communications, 1994
- SP‐40,40, a protein involved in the control of the complement pathway, possesses a unique array of disulphide bridgesFEBS Letters, 1992
- The molecular pathology of Alzheimer's diseaseNeuron, 1991
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984